Biotech News
Related news
RXSTRxSight2026-08-05 20:05 EST
RxSight, Inc. Reports Second Quarter 2026 Results and Provides Update on 2026 Outlook
RXSTRxSight2026-07-06 20:15 EST
RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement
ICUIICU Medical2026-08-06 20:05 EST
ICU Medical Announces Second Quarter 2026 Results and Updates its Fiscal Year 2026 Guidance
MMSIMerit Medical2026-07-30 20:05 EST
Merit Medical Reports Second Quarter 2026 Results And Updates Full-Year 2026 Guidance
ACHCAcadia Healthcare2026-07-28 20:05 EST
Acadia Healthcare Announces Second Quarter 2026 Results and Updates Full Year 2026 Financial and Cash Flow Guidance
ANGOAngioDynamics2026-07-14 10:00 EST
AngioDynamics Reports Record Fiscal Year 2026 Fourth Quarter and Full Year Financial Results; Continued Execution Drives Med Tech Growth and Full-Year Profitability
ANGOAngioDynamics2026-06-30 12:00 EST
AngioDynamics to Report Fiscal 2026 Fourth Quarter and Full-Year Financial Results on July 14, 2026
XAIRBeyond Air2026-06-26 11:00 EST
Beyond Air® Reports Fourth Quarter and Full Year 2026 Financial Results and Provides Corporate Update
FEMYFEMASYS2026-08-14 20:05 EST
Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update
XAIRBeyond Air2026-08-13 11:00 EST
Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update
RxSight
Adjustable Cataract Lenses RxSight is an ophthalmic medical-device company focused on customized vision after cataract surgery. Light Adjustable Lens System The system combines an implantable Light Adjustable Lens with a Light Delivery Device. After surgery, physicians use ultraviolet light treatments to modify the lens and refine the...
Recent company news
RXSTRxSight2026-08-05 20:05 EST
RxSight, Inc. Reports Second Quarter 2026 Results and Provides Update on 2026 Outlook
RXSTRxSight2026-07-26 20:00 EST
RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
RXSTRxSight2026-07-15 20:15 EST
RxSight Announces Appointments of Aziz Mottiwala as Chief Executive Officer and Ron Kurtz, M.D. as Chief Medical Officer
RXSTRxSight2026-07-06 20:16 EST
Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs
RXSTRxSight2026-07-06 20:15 EST
RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement
Stock data
- Close
- 6.25 USD
- Market cap
- 204.5M USD
- Exchange
- NASDAQ
- Sector
- Biopharma
- Location
- United States